Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 9, 2009

View Archived Issues

Preclinical studies prepare antimalarial GSK-932121 for clinical development

ARQ-501 synergistic with NU-7026 against metastatic breast cancer cells

Etifoxine aids peripheral nerve recovery

Peptide blocking enhancer of NMDAR function suppresses pain hypersensitivity

Phase I study of ON-1910Na in solid tumor patients identifies phase II dose

Abbott acquires Isis Pharmaceuticals' subsidiary Ibis Biosciences

Amira successfully completes toxicity studies for AM-211 and will submit IND in mid-2009

Onyx acquires option to license rights to S*BIO's JAK2 inhibitors SB-1518 and SB-1578

Phosphagenics reports results from trial of TPM/insulin in diabetic patients

MiddleBrook to launch Moxatag in March 2009 for tonsillitis and pharyngitis

Circassia completes patient recruitment in phase II clinical trial of ToleroMune in cat allergy

Warner Chilcott and Dong-A sign U.S. license agreement for udenafil in erectile dysfunction

PPD and Merck & Co. enter into strategic collaboration for vaccine testing

Preliminary analysis shows no conclusive advantage of oral HMPL-002 in NSCLC

Peplin presents positive results from phase IIb PEP-005 trial in actinic keratosis

ANA-598 shows potent antiviral activity in HCV-infected patients

Crucell and Wyeth are discussing a combination of the two companies

FDA issues a complete response letter for Lilly's olanzapine in schizophrenia

Daiichi files application for KMD-3212 in China for dysuria

Plexxikon and Roche partner to develop PLX-5568 for polycystic kidney disease

Galderma's Epiduo gel now available in the U.S. to treat acne

Novel antibody-drug conjugates for the treatment of cancer engineered by scientists at Genentech

New chemokine CXCR2 receptor antagonists disclosed in recent Novartis patent

Recent Argenta Discovery patent describes new HNE inhibitors for treatment of respiratory disorders

Janssen has synthesized novel DGAT-1 inhibitors with potental as antidiabetic agents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...